Cited 35 times in
CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김형범 | - |
dc.contributor.author | 호사발레랑가파바라티 | - |
dc.date.accessioned | 2018-03-26T16:56:03Z | - |
dc.date.available | 2018-03-26T16:56:03Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0304-419X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/156977 | - |
dc.description.abstract | While human gene therapy has gained significant attention for its therapeutic promise, CRISPR/Cas9 technology has made a breakthrough as an efficient genome editing tool by emulating prokaryotic immune defense mechanisms. Although many studies have found that CRISPR/Cas9 technology is more efficient, specific and manipulable than previous generations of gene editing tools, it can be further improved by elevating its overall efficiency in a higher frequency of genome modifications and reducing its off-target effects. Here, we review the development of CRISPR/Cas9 technology, focusing on enhancement of its sequence specificity, reduction of off-target effects and delivery systems. Moreover, we describe recent successful applications of CRISPR/Cas9 technology in laboratory and clinical studies. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier Pub. Co. | - |
dc.relation.isPartOf | BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Base Sequence | - |
dc.subject.MESH | CRISPR-Associated Proteins/genetics* | - |
dc.subject.MESH | CRISPR-Cas Systems/genetics* | - |
dc.subject.MESH | Clustered Regularly Interspaced Short Palindromic Repeats/genetics* | - |
dc.subject.MESH | DNA/genetics* | - |
dc.subject.MESH | Genetic Engineering/methods* | - |
dc.subject.MESH | Molecular Sequence Data | - |
dc.subject.MESH | Reproducibility of Results | - |
dc.subject.MESH | Sensitivity and Specificity | - |
dc.subject.MESH | Transfection/methods* | - |
dc.title | CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Pharmacology | - |
dc.contributor.googleauthor | Young-Il Jo | - |
dc.contributor.googleauthor | Bharathi Suresh | - |
dc.contributor.googleauthor | Hyongbum Kim | - |
dc.contributor.googleauthor | Suresh Ramakrishna | - |
dc.identifier.doi | 10.1016/j.bbcan.2015.09.003 | - |
dc.contributor.localId | A01148 | - |
dc.contributor.localId | A04705 | - |
dc.relation.journalcode | J02904 | - |
dc.identifier.eissn | 1878-2434 | - |
dc.identifier.pmid | 26434948 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0304419X15000700 | - |
dc.subject.keyword | CRISPR/Cas9 applications | - |
dc.subject.keyword | Delivery methods | - |
dc.subject.keyword | Genome editing | - |
dc.subject.keyword | Reduced off-target effects | - |
dc.subject.keyword | Sequence specificity | - |
dc.subject.keyword | Therapeutics | - |
dc.contributor.alternativeName | Kim, Hyongbum | - |
dc.contributor.alternativeName | Ramakrishna, S | - |
dc.contributor.affiliatedAuthor | Kim, Hyongbum | - |
dc.contributor.affiliatedAuthor | Ramakrishna, S | - |
dc.citation.volume | 1856 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 234 | - |
dc.citation.endPage | 243 | - |
dc.identifier.bibliographicCitation | BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, Vol.1856(2) : 234-243, 2015 | - |
dc.identifier.rimsid | 41286 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.